(Q35071885)

6 August 2017

1 reference

title

Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy (English)

1 reference

6 August 2017

G Kircheis

1

1 reference

6 August 2017

M Wettstein

series ordinal

2

1 reference

6 August 2017

S vom Dahl

series ordinal

3

1 reference

6 August 2017

D Häussinger

series ordinal

4

1 reference

6 August 2017

publication date

1 December 2002

1 reference

6 August 2017

published in

Metabolic Brain Disease

1 reference

6 August 2017

volume

17

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

453-462

1 reference

[Clinical aspects of acute liver insufficiency.]

6 August 2017

cites work

1 reference

12 December 2020

Functional hepatocyte heterogeneity. Vascular 2-oxoglutarate is almost exclusively taken up by perivenous, glutamine-synthetase-containing hepatocytes

1 reference

12 December 2020

[Influence of ornithine aspartate on the experimentally induced hyperammoniemia. Clinico-experimental study]

1 reference

12 December 2020

Skeletal muscle and whole-body protein turnover in cirrhosis

1 reference

12 December 2020

Hepatocyte heterogeneity in glutamine and ammonia metabolism and the role of an intercellular glutamine cycle during ureogenesis in perfused rat liver

1 reference

12 December 2020

Hyperammonaemia causes many of the changes found after portacaval shunting

1 reference

12 December 2020

Hepatocyte heterogeneity in ammonia metabolism: impairment of glutamine synthesis in CCl4 induced liver cell necrosis with no effect on urea synthesis

1 reference

12 December 2020

Ammonia and glutamine metabolism in human liver slices: new aspects on the pathogenesis of hyperammonaemia in chronic liver disease

1 reference

12 December 2020

Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design

1 reference

12 December 2020

Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.

1 reference

12 December 2020

Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.

1 reference

12 December 2020

Treatment of hepatic encephalopathy

1 reference

12 December 2020

Therapy of severe hyperammonemia

1 reference

12 December 2020

Functional hepatocyte heterogeneity in glutamate, aspartate and α-ketoglutarate uptake: A histoautoradiographical study

1 reference

12 December 2020

[Changes of plasma amino acids in cirrhotics treated with ornithine salts]

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1021934607762

1 reference

Dimensions Publication ID

6 August 2017

1046721876

0 references

1 reference